Effect of hepatic lipase -514C → T polymorphism and its interactions with apolipoprotein C3 -482C → T and apolipoprotein E exon 4 polymorphisms on the risk of nephropathy in Chinese type 2 diabetic patients

Diabetes Care

Volumn 28, Issue 7, 2005, Pages 1704-1709

  Baum, Larry ^a   Ng, Maggie C Y ^a   So, Wing Yee ^a   Lam, Vincent K L ^a   Wang, Ying ^a   Poon, Emily ^a   Tomlinson, Brian ^a   Cheng, Suzanne ^b   Lindpaintner, Klaus ^c   Chan, Juliana C N ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b ROCHE MOLECULAR SYSTEMS   (United States)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; CREATININE; DNA; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; DNA POLYMORPHISM; DYSLIPIDEMIA; ENZYME ACTIVITY; EXON; FEMALE; GENOTYPE; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PROTEINURIA; RISK FACTOR; SEX DIFFERENCE; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; CASE-CONTROL STUDIES; CHIN; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; EXONS; FEMALE; GENOTYPE; HUMANS; LIPASE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING; VASCULAR DISEASES;

EID: 21544442861     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.7.1704     Document Type: Article

References (29)

1. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease: ease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161-1165, 1989
2. Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R: Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 158:998-1004, 1998
3. Wang Y, Ng MC, Lee SC, So WY, Tong PC, Cockram CS, Critchley JA, Chan JC: Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes. Diabetes Care 26:2410-2415, 2003
4. Hirano T: Lipoprotein abnormalities in diabetic nephropathy. Kidney Int (Suppl. 71): S22-S24, 1999
5. Guerra R, Wang J, Grundy SM, Cohen JC: A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci USA 94:4532-4537, 1997
6. Andersen RV, Wittrup HH, Tybjaerg-Hansen A, Steffensen R, Schnohr P, Nordestgaard BG: Hepatic lipase mutations, elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study. J Am Coll Cardiol 41:1972-1982, 2003
7. Jansen H, Waterworth DM, Nicaud V, Ehnholm C, Talmud PJ: Interaction of the common apolipoprotein C-III (APOC3 -482C → T) and hepatic lipase (LIPC -514C → T) promoter variants affects glucose tolerance in young adults: European Atherosclerosis Research Study II (EARS-II). Ann Intern Med 65:237-243, 2001
8. Rogus JJ, Warram JH, Krolewski AS: Genetic studies of late diabetic complications: the overlooked importance of diabetes duration before complication onset. Diabetes 51:1655-1662, 2002
9. Cheng S, Grow MA, Pallaud C, Klitz W, Erlich HA, Visvikis S, Chen JJ, Pullinger CR, Malloy MJ, Siest G, Kane JP: A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res 9:936-949, 1999
10. Ng MC, Wang Y, So WY, Cheng S, Visvikis S, Zee RY, Fernandez-Cruz A, Lindpaintner K, Chan JC: Ethnic differences in the linkage disequilibrium and distribution of single-nucleotide polymorphisms in 35 candidate genes for cardiovascular diseases. Genomics 83:559-565, 2004
11. Orchard TJ, Chang YF, Ferrell RE, Petro N, Ellis DE: Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int 62:963-970, 2002
12. Cooper ME: Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 352:213-219, 1998
13. Nishida Y, Oda H, Yorioka N: Effect of lipoproteins on mesangial cell proliferation. Kidney Int (Suppl. 71):S51-S53, 1999
14. Botma GJ, Verhoeven AJ, Jansen H: Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by upstream stimulatory factor. Atherosclerosis 154:625-632, 2001
15. Skoglund-Andersson C, Ehrenborg E, Fisher RM, Olivecrona G, Hamsten A, Karpe F: Influence of common variants in the CETP, LPL, HL and APO E genes on LDL heterogeneity in healthy, middle-aged men. Atherosclerosis 167:311-317, 2003
16. Tan KC, Shiu SW, Chu BY: Effects of gender, hepatic lipase gene polymorphism and type 2 diabetes mellitus on hepatic lipase activity in Chinese. Atherosclerosis 157:233-239, 2001
17. Ordovas JM, Corella D, Demissie S, Cupples LA, Couture P, Coltell O, Wilson PW, Schaefer EJ, Tucker KL: Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: evidence of a strong dose effect in this gene-nutrient interaction in the Framingham Study. Circulation 106: 2315-2321, 2002
18. Tai ES, Corella D, Deurenberg-Yap M, Cutter J, Chew SK, Tan CE, Ordovas JM, Singapore National Health Survey: Dietary fat interacts with the -514C → T polymorphism in the hepatic lipase gene promoter on plasma lipid profiles in a multiethnic Asian population: the 1998 Singapore National Health Survey. J Nutr 133:3399-3408, 2003
19. Todorova B, Kubaszek A, Pihlajamaki J, Lindstrom J, Eriksson J, Valle TT, Hamalainen H, Ilanne-Parikka P, Kemanen-Kiukaanniemi S, Tuomilehio J, Uusitupa M, Laakso M: The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study. J Clin Endocrinol Metab 89:2019-2023, 2004
20. Hokanson JE, Cheng S, Snell-Bergeon JK, Fijal BA, Grow MA, Hung C, Erlich HA, Ehrlich J, Eckel RH, Rewers M: A common promoter polymorphism in the hepatic lipase gene (LIPC-480C → T) is associated with an increase in coronary calcification in type 1 diabetes. Diabetes 51:1208-1213, 2002
21. Fan YM, Salonen JT, Koivu TA, Tuomainen TP, Nyyssonen K, Lakka TA, Salonen R, Seppanen K, Nikkari ST, Tahvanainen E, Lehtimaki T: Hepatic lipase C-480T polymorphism modifies the effect of HDL cholesterol on the risk of acute myocardial infarction in men: a prospective population based study. J Med Genet 41:e28, 2004
22. Sheetz MJ, King GL: Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 288:2579-2588, 2002
23. Singleton JR, Smith AG, Russell JW, Feldman EL: Microvascular complications of impaired glucose tolerance. Diabetes 52: 2867-2873, 2003
24. Haddy N, De BD, Chemaly MM, Maurice M, Ehnholm C, Evans A, Sans S, Do Carmo MM, De BG, Siest G, Visvikis S: The importance of plasma apolipoprotein E concentration in addition to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe. Eur J Hum Genet 10:841-850, 2002
25. Jansen H, Chu G, Ehnholm C, Dallongeville J, Nicaud V, Talmud PJ: The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased pre-prandial and postprandial LpCIII:B: European Atherosclerosis Research Study (EARS) II. Arterioscler Thromb Vasc Biol 19:303-308, 1999
26. Ashavaid TF, Shalia KK, Kondkar AA, Todur SP, Nair KG, Nair SR: Gene polymorphism and coronary risk factors in Indian population. Clin Chem Lab Med 40:975-985, 2002
27. Tu AY, Albers JJ: Glucose regulates the transcription of human genes relevant to HDL metabolism: responsive elements for peroxisome proliferator-activated receptor are involved in the regulation of phospholipid transfer protein. Diabetes 50: 1851-1856, 2001
28. Pirart J: [Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973]. Diabetes Metab 3:97-107, 1977 [article in French]
29. Chavers BM, Mauer SM, Ramsay RC, Steffes MW: Relationship between retinal and glomerular lesions in IDDM patients. Diabetes 43:441-446, 1994